Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Schlaberg

Showing results (11-20 of 57) with videos related to

Pageof 6
Sort By:
Emerging Infectious Diseases|March 2, 2012
A systematic approach for discovering novel, clinically relevant bacteriaRobert Schlaberg, Keith E Simmon, Mark A Fisher
Journal of Clinical Microbiology|November 16, 2007
Nocardia cyriacigeorgica, an emerging pathogen in the United StatesRobert Schlaberg, Richard C Huard, Phyllis Della-Latta
Antimicrobial Agents and Chemotherapy|November 20, 2013
Susceptibility profiles of Nocardia isolates based on current taxonomyRobert Schlaberg, Mark A Fisher, Kimberley E Hanson
Journal of Clinical Microbiology|July 11, 2014
Antepartum screening for group B Streptococcus by three FDA-cleared molecular tests and effect of shortened enrichment culture on molecular detection ratesBrianne A Couturier, Trent Weight, Haley Elmer, et al.
Waste Management & Research : the Journal of the International Solid Wastes and Public Cleansing Association, ISWA|December 29, 2005
Separation of fine binary mixtures under vibration in a gas-solid fluidized bed with dense mediumHaibo Jin, Zemin Tong, H Inaki Schlaberg, et al.
Sexually Transmitted Infections|May 16, 2014
Chlamydia trachomatis L serovars and dominance of novel L2b ompA variants, U.S.ABrian A Kendall, Keith D Tardif, Robert Schlaberg
Archives of Pathology & Laboratory Medicine|January 3, 2012
Verification of performance specifications for a US Food and Drug Administration-approved molecular microbiology test: Clostridium difficile cytotoxin B using the Becton, Dickinson and Company GeneOhm Cdiff assayRobert Schlaberg, Michael J Mitchell, Edward W Taggart, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|September 11, 2014
Simultaneous titration and phenotypic antiviral drug susceptibility testing for herpes simplex virus 1 and 2Keith D Tardif, Shane Jorgensen, Janine Langer, et al.
Journal of Clinical Microbiology|February 21, 2014
Testing and genotyping of high-risk human papillomavirus by the cobas HPV Test and the Hybrid Capture 2 high-risk HPV DNA test using cervical and vaginal samplesMichael T Pyne, Christian Law, David R Hillyard, et al.
Journal of Virological Methods|May 10, 2015
High-risk HPV detection and genotyping by APTIMA HPV using cervical samplesMichael T Pyne, Camille L Hamula, Keith Tardif, et al.
Pageof 6

Showing results (11-20 of 57) with videos related to

Sort By:
Pageof 6
Emerging Infectious Diseases|March 2, 2012
A systematic approach for discovering novel, clinically relevant bacteriaRobert Schlaberg, Keith E Simmon, Mark A Fisher
Journal of Clinical Microbiology|November 16, 2007
Nocardia cyriacigeorgica, an emerging pathogen in the United StatesRobert Schlaberg, Richard C Huard, Phyllis Della-Latta
Antimicrobial Agents and Chemotherapy|November 20, 2013
Susceptibility profiles of Nocardia isolates based on current taxonomyRobert Schlaberg, Mark A Fisher, Kimberley E Hanson
Journal of Clinical Microbiology|July 11, 2014
Antepartum screening for group B Streptococcus by three FDA-cleared molecular tests and effect of shortened enrichment culture on molecular detection ratesBrianne A Couturier, Trent Weight, Haley Elmer, et al.
Waste Management & Research : the Journal of the International Solid Wastes and Public Cleansing Association, ISWA|December 29, 2005
Separation of fine binary mixtures under vibration in a gas-solid fluidized bed with dense mediumHaibo Jin, Zemin Tong, H Inaki Schlaberg, et al.
Sexually Transmitted Infections|May 16, 2014
Chlamydia trachomatis L serovars and dominance of novel L2b ompA variants, U.S.ABrian A Kendall, Keith D Tardif, Robert Schlaberg
Archives of Pathology & Laboratory Medicine|January 3, 2012
Verification of performance specifications for a US Food and Drug Administration-approved molecular microbiology test: Clostridium difficile cytotoxin B using the Becton, Dickinson and Company GeneOhm Cdiff assayRobert Schlaberg, Michael J Mitchell, Edward W Taggart, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|September 11, 2014
Simultaneous titration and phenotypic antiviral drug susceptibility testing for herpes simplex virus 1 and 2Keith D Tardif, Shane Jorgensen, Janine Langer, et al.
Journal of Clinical Microbiology|February 21, 2014
Testing and genotyping of high-risk human papillomavirus by the cobas HPV Test and the Hybrid Capture 2 high-risk HPV DNA test using cervical and vaginal samplesMichael T Pyne, Christian Law, David R Hillyard, et al.
Journal of Virological Methods|May 10, 2015
High-risk HPV detection and genotyping by APTIMA HPV using cervical samplesMichael T Pyne, Camille L Hamula, Keith Tardif, et al.
Pageof 6